Our current findings expand upon this body of work and highlight the potential of targeting TrkB to reverse cognitive deficits caused by severe neuronal loss, a feature that is absent in many models of neurodegenerative disease. The gene discussed is NTRK2; the disease is neurodegenerative disease.